Cutting-Edge Imaging of Cardiac Metastases from Neuroendocrine Tumors: Lesson from a Case Series

Soraya El Ghannudi, Eric Ouvrard, Nidaa Mikail, Benjamin Leroy Freschini, Thomas H. Schindler, Alessio Imperiale

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


With the increasing availability of high-performance medical imaging for the management of patients with neuroendocrine tumors (NETs), a progressive growth of asymptomatic and incidentally detected cardiac metastases (CMs) has been observed in the recent years. In clinical practice, CMs of NENs are often incidentally detected by whole-body68Ga-labeled somatostatin analogs or18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography, and afterwards accurately characterized by cardiac magnetic resonance (CMR) and/or gated cardiac computed tomography when CMR is contraindicated or not available. The interpreting physician should familiarize with the main imaging features of CM, a finding that may be encountered in NETs patients more than previously thought. Herein, we present a case series of four patients with CMs from small-intestine NETs highlighting strengths and weaknesses of a multimodality imaging approach in clinical practice.

Original languageEnglish
Article number1182
Issue number5
StatePublished - May 2022


  • 1 F-DOPA
  • cardiac imaging
  • cardiac magnetic resonance
  • cardiac metastasis
  • echocardiography
  • neuroendocrine
  • positron emission tomography


Dive into the research topics of 'Cutting-Edge Imaging of Cardiac Metastases from Neuroendocrine Tumors: Lesson from a Case Series'. Together they form a unique fingerprint.

Cite this